← Evidence map

ReviewMini reviews in medicinal chemistry2024

The Development of HDAC and Tubulin Dual-Targeting Inhibitors for Cancer Therapy.

Jing Nie et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37461341